glp-1 weight loss drug news today 2025 obesity A nice article in The Hindu today highlights the Chart: 1 in 8 Americans
Description
The institute recommended that existing GLP-1 makers, and those with products in the pipeline, should consider steep discounts to prices in exchange for higher volume. What has to happen is we have to move from a low-volume, high-price business model, to a high-volume, low-price business model, Nunn said
M., Dyck, D
10.1007/s12020-019-01891-3 93 SmitsM
doi: 10.1210/er.2014-1035
This ongoing innovation promises a future where these powerful hormonal therapies can be tailored more precisely to individual patient needs, offering new hope for a variety of chronic diseases
2020;5:e133429
